We are live on
!
Find out more
YIH
Y-Intercept (HK) Portfolio holdings
AUM
$5.05B
1-Year Est. Return
17.89%
This Fund
S&P 500
This Quarter
Est. Return
+8.14%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
–
AUM
$4.09B
AUM Growth
+$2.61B
(+177%)
Cap. Flow
+$2.46B
Cap. Flow
% of AUM
60.1%
Top 10 Holdings %
Top 10 Hldgs %
6.33%
Holding
2,105
New
963
Increased
487
Reduced
137
Closed
518
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$37.8M |
| 2 |
Sarepta Therapeutics
SRPT
|
+$35.1M |
| 3 |
T-Mobile US
TMUS
|
+$30.4M |
| 4 |
Nu Holdings
NU
|
+$27.8M |
| 5 |
Consolidated Edison
ED
|
+$26.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$17M |
| 2 |
Marvell Technology
MRVL
|
+$16.2M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$16.1M |
| 4 |
ServiceNow
NOW
|
+$13.3M |
| 5 |
Walmart Inc
WMT
|
+$10.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.87% |
| 2 | Industrials | 14.69% |
| 3 | Financials | 14.36% |
| 4 | Healthcare | 12.68% |
| 5 | Consumer Discretionary | 12.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Warby Parker
WRBY
$3.19B
| $259K | 0.01% |
+11,813
| New | +$218K |
|
1402
Ultralife
ULBI
$88.3M
| $259K | 0.01% |
+28,809
| New | +$171K |
|
1403
RadNet
RDNT
$4.98B
| $256K | 0.01% |
4,502
-13,169
| -75% | -$723K |
|
1404
PRA Group
PRAA
$672M
| $255K | 0.01% |
17,284
+3,050
| +21% | +$48.6K |
|
1405
Northern Technologies International Corp
NTIC
$75.6M
| $254K | 0.01% |
+34,325
| New | +$262K |
|
1406
1stdibs.com
DIBS
$148M
| $254K | 0.01% |
+92,396
| New | +$239K |
|
|
SMC
1407
Summit Midstream
SMC
$420M
| $253K | 0.01% |
+10,331
| New | +$284K |
|
1408
JPMorgan US Quality Factor ETF
JQUA
$8.14B
| $249K | 0.01% |
+4,139
| New | +$237K |
|
1409
Towne Bank
TOWN
$3.54B
| $248K | 0.01% |
+7,262
| New | +$242K |
|
|
HSII
1410
DELISTED
Heidrick & Struggles
HSII
| $247K | 0.01% |
+5,404
| New | +$227K |
|
1411
Tenaris
TS
$28.2B
| $247K | 0.01% |
6,596
-14,695
| -69% | -$504K |
|
1412
ACM Research
ACMR
$4.51B
| $244K | 0.01% |
9,422
+221
| +2% | +$4.97K |
|
1413
Banc of California
BANC
$2.87B
| $244K | 0.01% |
+17,350
| New | +$236K |
|
1414
SkyWater Technology
SKYT
$1.5B
| $243K | 0.01% |
+24,681
| New | +$199K |
|
1415
Global X Defense Tech ETF
SHLD
$6.92B
| $242K | 0.01% |
+4,021
| New | +$216K |
|
1416
Old Second Bancorp
OSBC
$1.29B
| $241K | 0.01% |
13,610
-19,927
| -59% | -$325K |
|
1417
Telephone and Data Systems
TDS
$3.87B
| $241K | 0.01% |
+6,779
| New | +$238K |
|
1418
JPMorgan BetaBuilders Europe ETF
BBEU
$9.17B
| $240K | 0.01% |
+3,563
| New | +$230K |
|
|
URG
1419
Ur-Energy
URG
$469M
| $240K | 0.01% |
+228,817
| New | +$183K |
|
1420
DLH Holdings
DLHC
$78.3M
| $239K | 0.01% |
+40,979
| New | +$185K |
|
|
EMA
1421
Emera Inc
EMA
$16.5B
| $239K | 0.01% |
+5,220
| New | +$234K |
|
1422
Smith-Midland
SMID
$155M
| $238K | 0.01% |
+7,083
| New | +$216K |
|
1423
Clarivate
CLVT
$1.38B
| $236K | 0.01% |
+54,951
| New | +$221K |
|
1424
IHS Holding
IHS
$2.78B
| $234K | 0.01% |
+42,048
| New | +$226K |
|
1425
Opendoor
OPEN
$3.54B
| $233K | 0.01% |
+451,508
| New | +$326K |
|
Similar funds
HSA
O
LFG
JIM
CTC
NL
BPWM
VT
Y-Intercept (HK)'s Q2 2025 Portfolio in Review
As of Q2 2025, Y-Intercept (HK) held 2,105 positions worth $4.09B, up 177% from $1.48B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Y-Intercept (HK) deployed $2.46B of net new capital in Q2 2025, opening 963 new positions and adding to 487 existing holdings. Its largest new stake was Nu Holdings: 2,319,643 shares worth $31.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 19% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Novo Nordisk, an estimated $16.1M trimmed.
- Y-Intercept (HK)'s largest Q2 2025 buy was Nu Holdings: 2,319,643 shares worth $31.8M.
- Y-Intercept (HK) added most to UnitedHealth in Q2 2025, an estimated $37.8M increase.
- Y-Intercept (HK)'s biggest Q2 2025 reduction was Novo Nordisk, cutting an estimated $16.1M.
- Y-Intercept (HK) fully exited Arista Networks in Q2 2025, selling an estimated $17M.
- Y-Intercept (HK)'s ten largest holdings make up 6.3% of its $4.09B portfolio in Q2 2025.
- Y-Intercept (HK) opened 963 new positions and closed 518 in Q2 2025.
- Y-Intercept (HK)'s portfolio value rose 177% quarter-over-quarter to $4.09B.
Based on Y-Intercept (HK)'s 13F filing for Q2 2025, filed 1 Aug 2025.